CARDIOVASCULAR CARDIOVASCULAR LIFE-CHANGING MEDICAL DEVICE TECHNOLOGIES AND SOLUTIONS THAT TREAT CARDIOVASCULAR CONDITIONS. FIND INFORMATION ABOUT CARDIOVASCULAR PRODUCTS AND THERAPIES FOR HEALTHCARE PROFESSIONALS FOR HEALTHCARE CONSUMERS & CAREGIVERS CARDIAC AND VASCULAR SOLUTIONS Healthcare professionals can find the information they need about innovations in cardiovascular technology that improve lives and help care for patients. GET PRODUCT DETAILS FOR HEALTHCARE PROFESSIONALS Find information to help you treat your patients with proven cardiovascular technologies and procedures. PRODUCT INFORMATION REIMBURSEMENT AND CODING MANUALS AND TECHNICAL RESOURCES EDUCATION AND TRAINING GOING BEYOND INTERVENTION SEE HOW WE'RE REIMAGINING PATIENT CARE AND CONNECTING THE CARE CONTINUUM READ THE WHITE PAPER FOR HEALTHCARE CONSUMERS & CAREGIVERS We partner with your care team on your heart health so you and your loved ones can get back to living your life to the fullest. MANAGE YOUR ID CARD LIVING WITH YOUR DEVICE NEW FROM ABBOTT ABBOTT CONFIRMS CAPACITY TO SUPPORT EXPANDED USE OF HEARTMATE 3™ HEART PUMP Abbott announced the company has capacity and supply to effectively support the growing demand for mechanical circulatory support (MCS) devices for the effective treatment of advanced heart failure following Medtronic's decision to stop the global distribution and sale of the Medtronic HeartWare™ ventricular assist device (HVAD). ADDRESSING HIGH BLOOD PRESSURE TO REDUCE HEALTH DISPARITIES IN CENTRAL TEXAS UNDERSERVED COMMUNITIES The American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, and the global healthcare company Abbott, today announced a new multi-year initiative to reduce high blood pressure and chronic diseases affecting historically underserved local communities in Austin, Texas. ABBOTT SEEKS BETTER TREATMENT OPTIONS FOR PATIENTS WITH BOTH ATRIAL FIBRILLATION AND HEART FAILURE WITH NEW TRIAL Abbott announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AFib) and heart failure. The first-of-its-kind trial aims to provide new insights into more effective treatment for patients with AFib and heart failure, a complex combination that has historically presented significant challenges to physicians. MAT-2000475 v6.0 CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. Illustrations are artist's representations only and should not be considered as engineering drawings or photographs. Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner. © 2021 Abbott. All Rights Reserved. MAT-1900882 v6.0 Feedback